Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer

Fangfang Duan; Dongwei Jia; Junjie Zhao; Weicheng Wu; Lingqiang Min; Shushu Song; Hao Wu; Lan Wang; Hongshan Wang; Yuanyuan Ruan; Jianxin Gu

doi:10.18632/oncotarget.9538

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer

Fangfang Duan, Dongwei Jia, Junjie Zhao, Weicheng Wu, Lingqiang Min, Shushu Song, Hao Wu, Lan Wang, Hongshan Wang _, Yuanyuan Ruan and Jianxin Gu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:38427-38439. https://doi.org/10.18632/oncotarget.9538

Metrics: PDF 1959 views | HTML 2781 views | ?

Abstract

Fangfang Duan1,2,3,*, Dongwei Jia1,2,*, Junjie Zhao4,*, Weicheng Wu1,2, Lingqiang Min4, Shushu Song1,2, Hao Wu1,2, Lan Wang1,2,3, Hongshan Wang4, Yuanyuan Ruan1,2, Jianxin Gu1,2,3

1Key Laboratory of Glycoconjugate Research Ministry of Public Health, School of Basic Medical Sciences, Fudan University, Shanghai, P.R. China

2Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P.R.China

3Institutes of Biomedical Sciences, Fudan University, Shanghai, P.R. China

4Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P.R. China

*These authors contributed equally to this work

Correspondence to:

Hongshan Wang, email: [email protected]

Yuanyuan Ruan, email: [email protected]

Keywords: GFAT1, gastric cancer, epithelial-to-mesenchymal transition, prognostic factor, TGF-β1

Received: January 22, 2016 Accepted: May 08, 2016 Published: May 21, 2016

ABSTRACT

Gastric cancer remains the third leading cause of cancer-related mortality worldwide, and invasion and metastasis of gastric cancer represent the major reason for its poor prognosis. Glutamine: fructose-6-phosphate amidotransferase 1 (GFAT1) is the first and rate-limiting enzyme of hexosamine biosynthesis pathway (HBP). Nevertheless, the role of GFAT1 in gastric cancer is little investigated. In this study, we found that the expression of GFAT1 was decreased in gastric cancer. Low expression of GFAT1 was positively associated with vessel invasion, late T stage, lymph node metastasis, distant metastasis, advanced TNM stage and poor prognosis in patients with gastric cancer. Furthermore, in vitro and in vivo studies revealed that down-regulation of GFAT1 promoted epithelial-to-mesenchymal transition (EMT) and invasive activities in gastric cancer cells through inducing the expression of TGF-β1. The GFAT1 expression also significantly correlated with EMT-related factors in gastric cancer patients. Together, these findings indicate that GFAT1 functions as a novel suppressor of EMT and tumor metastasis in gastric cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9538

Publication Alerts

Research Papers:

Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer

Abstract